Only thing in common with DNDN is that Prr is using the same tech. for ovarian cancer treatment(testing phase 11b & 3 trials).
DNDN - postate cancer has been approve by FDA. PRR is doing trails 11b and 3 years to go/ approval if all are successful.
as i said before anything can happen with the trials from now till fda approval.(recently 2 ovarian cancer trials phase 3 were not submitted for FDA approval one i think by elli lilly)
DNDN is not a speculative stock. PRR is.
DNDN will be generating income. PRR will be seeking finance
DNDn US35.0 appr. PRR 10.5 cents AUD
I am a realist and hope all will be well with PRR trials.
Just for info - I am still holding 1.8 millions PRR shares since mar 09.
news about phase 3 trials soon imo, page-8
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |